Patents by Inventor Michael E. Dunn
Michael E. Dunn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12606618Abstract: The present disclosure provides monoclonal antibodies that bind to the natriuretic peptide receptor 1 (NPR1) protein, and methods of use thereof. In various embodiments of the disclosure, the antibodies are fully human antagonist antibodies that bind to NPR1. In some embodiments, the antibodies of the disclosure are useful for blocking NPR1 signaling and/or activity, thus providing a means of treating or preventing a disease, disorder, or condition associated with NPR1, including hypotension, in humans.Type: GrantFiled: December 6, 2022Date of Patent: April 21, 2026Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Michael E. Dunn, Lori C. Morton
-
Publication number: 20250333524Abstract: The present disclosure provides novel immunoglobulin proteins that bind to a human natriuretic peptide receptor 1 (NPR1) agonist, preferably an anti-NPR1 antibody. In certain embodiments, the proteins of the disclosure comprise at least one immunoglobulin variable domain that binds to an anti-NPR1 antibody. In certain embodiments, the proteins of the disclosure are useful in blocking and/or reversing the effect of an administered anti-NPR1 antibody. In certain embodiments, the antigen-binding proteins are useful for effective management of blood pressure and hemodynamics in humans.Type: ApplicationFiled: May 13, 2025Publication date: October 30, 2025Inventors: Michael E. DUNN, Lori C. MORTON, Neil STAHL, Tammy T. HUANG, Ishita CHATTERJEE, Vishal KAMAT, Ashique RAFIQUE
-
Patent number: 12325752Abstract: The present disclosure provides novel immunoglobulin proteins that bind to a human natriuretic peptide receptor 1 (NPR1) agonist, preferably an anti-NPR1 antibody. In certain embodiments, the proteins of the disclosure comprise at least one immunoglobulin variable domain that binds to an anti-NPR1 antibody. In certain embodiments, the proteins of the disclosure are useful in blocking and/or reversing the effect of an administered anti-NPR1 antibody. In certain embodiments, the antigen-binding proteins are useful for effective management of blood pressure and hemodynamics in humans.Type: GrantFiled: December 17, 2021Date of Patent: June 10, 2025Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Michael E. Dunn, Lori C. Morton, Neil Stahl, Tammy T. Huang, Ishita Chatterjee, Vishal Kamat, Ashique Rafique
-
Publication number: 20250034279Abstract: The present disclosure is related to methods of reducing blood pressure or effecting a hemodynamic change in a subject, the methods comprising administering to the subject a pharmaceutical composition comprising an agonist of natriuretic peptide receptor 1 (NPR1) (e.g., an agonist anti-NPR1 antibody).Type: ApplicationFiled: October 11, 2024Publication date: January 30, 2025Inventors: Michael E. DUNN, Aaron KITHCART, Benjamin Adam OLENCHOCK
-
Publication number: 20240327539Abstract: The present disclosure is related to methods of reducing blood pressure or effecting a hemodynamic change in a subject, the methods comprising administering to the subject a pharmaceutical composition comprising an agonist of natriuretic peptide receptor 1 (NPR1) (e.g., an agonist anti-NPR1 antibody).Type: ApplicationFiled: October 11, 2022Publication date: October 3, 2024Inventors: Michael E. DUNN, Aaron KITHCART, Benjamin Adam OLENCHOCK
-
Publication number: 20240309103Abstract: The present invention provides monoclonal antibodies that bind to the natriuretic peptide receptor 1 (NPR1) protein, and methods of use thereof. In various embodiments of the invention, the antibodies are fully human antibodies that bind to NPR1. In some embodiments, the antibodies of the invention are useful for activating NPR1 activity, thus providing a means of treating or preventing a disease, disorder or condition associated with NPR1 in humans.Type: ApplicationFiled: May 31, 2024Publication date: September 19, 2024Inventors: Michael E. DUNN, Jia SU, Jason MASTAITIS, Jesper GROMADA, Lori C. MORTON
-
Publication number: 20240059780Abstract: The present invention provides monoclonal antibodies that bind to the natriuretic peptide receptor 1 (NPR1) protein, and methods of use thereof. In various embodiments of the invention, the antibodies are fully human antibodies that bind to NPR1. In some embodiments, the antibodies of the invention are useful for activating NPR1 activity, thus providing a means of treating or preventing a disease, disorder or condition associated with NPR1 in humans.Type: ApplicationFiled: October 11, 2023Publication date: February 22, 2024Inventors: Michael E. DUNN, Jia SU, Jason MASTAITIS, Jesper GROMADA, Lori C. MORTON
-
Patent number: 11826196Abstract: A system including: a table assembly for supporting a subject in one or more examination positions; a table support assembly for supporting the table assembly, wherein the table support assembly includes: one or more moving mechanisms controlled to move the table assembly relative to a reference point along one or more axes, and to rotate the table assembly around the one or more axes; and a probe support assembly comprising: a grip for holding a probe; and an arrangement of a plurality of arms and joints controlled to movably support the probe that is held by the grip, wherein the probe support assembly is removably arranged at a predetermined position and orientation relative to the table support assembly to permit movement of the table support assembly and the probe support assembly for reproduction of a position and orientation of the probe relative to the subject supported by the table assembly.Type: GrantFiled: October 17, 2022Date of Patent: November 28, 2023Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Sam Cichon, Michael E. Dunn
-
Patent number: 11820826Abstract: The present invention provides monoclonal antibodies that bind to the natriuretic peptide receptor 1 (NPR1) protein, and methods of use thereof. In various embodiments of the invention, the antibodies are fully human antibodies that bind to NPR1. In some embodiments, the antibodies of the invention are useful for activating NPR1 activity, thus providing a means of treating or preventing a disease, disorder or condition associated with NPR1 in humans.Type: GrantFiled: March 10, 2022Date of Patent: November 21, 2023Assignee: Regeneron Pharmaceuticals, Inc.Inventors: Michael E. Dunn, Jia Su, Jason Mastaitis, Jesper Gromada, Lori C. Morton
-
Publication number: 20230115770Abstract: A system including: a table assembly for supporting a subject in one or more examination positions; a table support assembly for supporting the table assembly, wherein the table support assembly includes: one or more moving mechanisms controlled to move the table assembly relative to a reference point along one or more axes, and to rotate the table assembly around the one or more axes; and a probe support assembly comprising: a grip for holding a probe; and an arrangement of a plurality of arms and joints controlled to movably support the probe that is held by the grip, wherein the probe support assembly is removably arranged at a predetermined position and orientation relative to the table support assembly to permit movement of the table support assembly and the probe support assembly for reproduction of a position and orientation of the probe relative to the subject supported by the table assembly.Type: ApplicationFiled: October 17, 2022Publication date: April 13, 2023Applicant: REGENERON PHARMACEUTICALS, INC.Inventors: Sam CICHON, Michael E. DUNN
-
Patent number: 11471124Abstract: A system including: a table assembly for supporting a subject in one or more examination positions; a table support assembly for supporting the table assembly, wherein the table support assembly includes: one or more moving mechanisms controlled to move the table assembly relative to a reference point along one or more axes, and to rotate the table assembly around the one or more axes; and a probe support assembly comprising: a grip for holding a probe; and an arrangement of a plurality of arms and joints controlled to movably support the probe that is held by the grip, wherein the probe support assembly is removably arranged at a predetermined position and orientation relative to the table support assembly to permit movement of the table support assembly and the probe support assembly for reproduction of a position and orientation of the probe relative to the subject supported by the table assembly.Type: GrantFiled: November 15, 2017Date of Patent: October 18, 2022Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Sam Cichon, Michael E. Dunn
-
Publication number: 20190328500Abstract: A system including: a table assembly for supporting a subject in one or more examination positions; a table support assembly for supporting the table assembly, wherein the table support assembly includes: one or more moving mechanisms controlled to move the table assembly relative to a reference point along one or more axes, and to rotate the table assembly around the one or more axes; and a probe support assembly comprising: a grip for holding a probe; and an arrangement of a plurality of arms and joints controlled to movably support the probe that is held by the grip, wherein the probe support assembly is removably arranged at a predetermined position and orientation relative to the table support assembly to permit movement of the table support assembly and the probe support assembly for reproduction of a position and orientation of the probe relative to the subject supported by the table assembly.Type: ApplicationFiled: November 15, 2017Publication date: October 31, 2019Inventors: Sam CICHON, Michael E. DUNN
-
Publication number: 20190002555Abstract: The present invention provides monoclonal antigen-binding proteins that bind to the cardiac glycoside marinobufagenin (MBG), and methods of use. In various embodiments of the invention, the antigen-binding proteins are fully human antigen-binding proteins that bind to MBG. In some embodiments, the antigen-binding proteins of the invention are useful for inhibiting or neutralizing MBG activity, thus providing a means of treating or preventing a MBG-associated disease or disorder selected from the group consisting of hypertension, myocardial fibrosis, uremic cardiomyopathy, heart failure, myocardial infarction, renal failure, renal fibrosis and pre-eclampsia.Type: ApplicationFiled: July 21, 2016Publication date: January 3, 2019Applicant: REGENERON PHARMACEUTICALS, INC.Inventors: Michael E. DUNN, Lori C. MORTON, Yonaton RAY, Jee H. KIM
-
Patent number: 6945199Abstract: The present invention relates to a coolant crossover member and intake manifold assembly adapted for use in a vehicle engine and method for producing the same. The crossover and manifold assembly includes crossover and a manifold. The crossover has a passage formed therein extending between a first end and a second end thereof. The manifold is joined to the first and second ends of the crossover. The manifold is provided with first and second openings which define first and second inner surfaces, respectively.Type: GrantFiled: September 24, 2003Date of Patent: September 20, 2005Assignee: Hayes Lemmerz International, Inc.Inventors: David T. Kapala, Michael E. Dunn, Marcello Tedesco, John S. Frait
-
Patent number: 6250431Abstract: A method to retain a minimum running clearance between the friction pads associated with a caliper of a brake and a rotor attached to a wheel of a vehicle. A bearing member associated with the wheel includes a plurality of rollers which axially move about a reference point to allow the rotor to correspondingly move and retract the friction pads of the caliper when the vehicle is subjected to centrifugal forces. This retraction of the friction pads by movement of the rotor creates a minimum running clearance between the rotor and friction pads on termination of the radial forces. A desired running clearance is reestablished during a brake application.Type: GrantFiled: March 1, 2000Date of Patent: June 26, 2001Assignee: Robert Bosch CorporationInventor: Michael E. Dunn
-
Patent number: 5542503Abstract: A rotor adapted for use in a vehicle disc brake assembly includes an inner annular mounting flange portion defining a rotational axis and an outer annular disc portion. The outer annular disc portion includes a pair of friction plates which are connected together in spaced apart relationship by a plurality of posts located about the circumference of the rotor. The plurality of posts are divided into a plurality of groups of four posts. Each group of four posts includes a first post and a second post which are radially aligned with one another along with respect to a first bisecting radius extending outwardly from the rotational axis of the rotor. Each group of four posts also includes a third post and a fourth post which are radially aligned with one another with respect to a second bisecting radius extending outwardly from the rotational axis of the rotor. The first common bisecting radius and the second common bisecting radius are disposed at a predetermined angle relative to one another.Type: GrantFiled: June 6, 1995Date of Patent: August 6, 1996Assignee: Kelsey-Hayes CompanyInventors: Michael E. Dunn, Don Varnelis
-
Patent number: 4008801Abstract: A conveyor belt guide comprises a plurality of guide sections, each including an integral polyurethane elongated rib and base web having a width substantially greater than the rib at its juncture with the web. The base web has a fabric backing molded thereon, upon molding of the rib and base web, at the side of the base web opposite the rib. Each section has tapered ends for cooperating with the ends of adjacent sections to prevent guide stripping. The base web has a greater thickness at its juncture to the rib than at its edges, thereby providing a predetermined primary wear area adjacent the rib and a low coefficient of friction between guide section and supporting slide bed. The sections are laid end-to-end into elongated relieved portions of multiple ply conveyor belts so the base web edges are within the belt plane, but the thicker portion of the belt supports the rib above the belt plane.Type: GrantFiled: June 19, 1975Date of Patent: February 22, 1977Assignee: F. N. Shepard & CompanyInventors: James E. Reilly, Frank A. Klaene, Michael E. Dunn